Cell UK: In-Person features 3 outstanding programmes, including over 80 cutting-edge presentations and discussions, over 10 hours of valuable networking sessions, and an exhibition hall showcasing 35+ vendor companies, taking place in London (UK) from October 28 to 29, 2021. Following this is a dedicated Digital Day delivered through our online event platform on November 1st, 2021.

Dr Magali Taiel, Chief Medical Officer, will give remotely an oral presentation on our lead product candidate LUMEVOQ® (GS010; lenadogene nolparvovec) as detailed below:


Thursday 28 October 2021

Time:  12:55 – 13:20 GMT

Title:  Lumevoq Gene Therapy In Leber Hereditary Optic Neuropathy (LHON)

  • LHON disease
  • Key results from Lumevoq phase III pivotal studies
  • Regulatory pathways and next steps